Satellos Bioscience (MSLE) Enterprise Value (2023 - 2026)

Satellos Bioscience (MSLE) has 4 years of Enterprise Value data on file, last reported at -$69.9 million in Q1 2026.

• On a quarterly basis, Enterprise Value changed N/A year-over-year to -$69.9 million in Q1 2026; TTM through Mar 2026 was -$69.9 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$27.7 million, up 44.59% from the prior year.
• Enterprise Value for Q1 2026 stood at -$69.9 million, down from -$27.7 million in the prior quarter.
• Over the last five years, Enterprise Value for MSLE reached as high as -$27.7 million in Q4 2025 and fell as low as -$69.9 million in Q1 2026.
• Historically, Enterprise Value has averaged -$44.2 million across 4 years, with a median of -$39.5 million in 2023.
• Across the five-year window, Enterprise Value sank 71.97% in 2024 and soared 44.59% in 2025, its largest moves.
• Year by year, Enterprise Value stood at -$29.1 million in 2023, then sank by 71.97% to -$50.0 million in 2024, then surged by 44.59% to -$27.7 million in 2025, then slumped by 152.3% to -$69.9 million in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were -$69.9 million in Q1 2026, -$27.7 million in Q4 2025, and -$50.0 million in Q4 2024.